Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of AdaptHealth Corp (NASDAQ: AHCO) closed at $8.50 in the last session, down -0.12% from day before closing price of $8.51. In other words, the price has decreased by -$0.12 from its previous closing price. On the day, 2.12 million shares were traded. AHCO stock price reached its highest trading level at $8.67 during the session, while it also had its lowest trading level at $8.32.
Ratios:
We take a closer look at AHCO’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.45 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.86. For the most recent quarter (mrq), Quick Ratio is recorded 1.09 and its Current Ratio is at 1.33. In the meantime, Its Debt-to-Equity ratio is 1.36 whereas as Long-Term Debt/Eq ratio is at 1.32.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on January 08, 2024, Downgraded its rating to Hold and sets its target price to $8 from $14.50 previously.
On November 08, 2023, BofA Securities Downgraded its rating to Underperform which previously was Neutral and also lowered its target price recommendation from $9.50 to $6.50.
Stifel Downgraded its Buy to Hold on May 10, 2023, whereas the target price for the stock was revised from $18 to $11.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 19 ’24 when Rietkerk Shaw bought 32,500 shares for $9.70 per share.
Clemens Jason A sold 35,000 shares of AHCO for $327,250 on Dec 10 ’24. The Chief Financial Officer now owns 420,719 shares after completing the transaction at $9.35 per share. On Dec 10 ’24, another insider, JASON A CLEMENS &BIANCA S VITA, who serves as the Officer of the company, bought 35,000 shares for $9.35 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AHCO now has a Market Capitalization of 1146369536 and an Enterprise Value of 3171034624. As of this moment, AdaptHealth’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.05, and their Forward P/E ratio for the next fiscal year is 6.95. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.10. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.35 while its Price-to-Book (P/B) ratio in mrq is 0.73. Its current Enterprise Value per Revenue stands at 0.972 whereas that against EBITDA is 4.727.
Stock Price History:
The Beta on a monthly basis for AHCO is 1.64, which has changed by -0.17153996 over the last 52 weeks, in comparison to a change of 0.092895746 over the same period for the S&P500. Over the past 52 weeks, AHCO has reached a high of $11.90, while it has fallen to a 52-week low of $7.11. The 50-Day Moving Average of the stock is -11.01%, while the 200-Day Moving Average is calculated to be -16.03%.
Shares Statistics:
According to the various share statistics, AHCO traded on average about 1.75M shares per day over the past 3-months and 1780040 shares per day over the past 10 days. A total of 134.60M shares are outstanding, with a floating share count of 86.60M. Insiders hold about 35.79% of the company’s shares, while institutions hold 74.66% stake in the company. Shares short for AHCO as of 1744675200 were 8470518 with a Short Ratio of 4.85, compared to 1741910400 on 9594591. Therefore, it implies a Short% of Shares Outstanding of 8470518 and a Short% of Float of 8.2100004.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
A detailed examination of AdaptHealth Corp (AHCO) is currently in progress, with 5.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $0.24, with high estimates of $0.32 and low estimates of $0.09.
Analysts are recommending an EPS of between $1.22 and $1.0 for the fiscal current year, implying an average EPS of $1.1. EPS for the following year is $1.24, with 5.0 analysts recommending between $1.39 and $0.87.
Revenue Estimates
According to 8 analysts, the current quarter’s revenue is expected to be $764.77M. It ranges from a high estimate of $768.49M to a low estimate of $762.9M. As of the current estimate, AdaptHealth Corp’s year-ago sales were $792.5MFor the next quarter, 8 analysts are estimating revenue of $808.16M. There is a high estimate of $818.27M for the next quarter, whereas the lowest estimate is $791M.
A total of 9 analysts have provided revenue estimates for AHCO’s current fiscal year. The highest revenue estimate was $3.3B, while the lowest revenue estimate was $3.23B, resulting in an average revenue estimate of $3.27B. In the same quarter a year ago, actual revenue was $3.26BBased on 9 analysts’ estimates, the company’s revenue will be $3.43B in the next fiscal year. The high estimate is $3.53B and the low estimate is $3.34B.
